Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Invokana CREDENCE Renal Outcomes Trial Stopped Early for Efficacy
SGLT2 inhibitors getting some renal function headlines today. Hopefully someday soon apabetalone will also receive some positive headlines in the areas of cardiovascular and and renal disease.
